Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

Journal of Urology

Volumn 197, Issue 2, 2017, Pages S200-S207

  Catalona, William J ^a,b,c,d,e,f   Richie, Jerome P ^a,b,c,d,e,f   Ahmann, Frederick R ^a,b,c,d,e,f   Hudson, M'Liss A ^a,b,c,d,e,f   Scardino, Peter T ^a,b,c,d,e,f   Flanigan, Robert C ^a,b,c,d,e,f   DeKernion, Jean B ^a,b,c,d,e,f   Ratliff, Timothy L ^a,b,c,d,e,f   Kavoussi, Louis R ^a,b,c,d,e,f   Dalkin, Bruce L ^a,b,c,d,e,f   Waters, W Bedford ^a,b,c,d,e,f   MacFarlane, Michael T ^a,b,c,d,e,f   Southwick, Paula C ^a,b,c,d,e,f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f Hybritech Incorporated   (United States)

Author keywords

antigens; diagnosis; neoplasm; prostatic neoplasms; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; DIGITAL RECTAL EXAMINATION; EARLY CANCER DIAGNOSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; VERY ELDERLY; BIOPSY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATE TUMOR; STANDARDS;

AGED; AGED, 80 AND OVER; BIOPSY; DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY;

EID: 85008622484     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2016.10.073     Document Type: Article

References (31)

1. 1 Cancer Facts and Figures—1992. Atlanta: American Cancer Society, 1992.
2. 2 Boring, C. C., Squires, T. S. and Tong, T.: Cancer statistics, 1993. CA, 43: 7, 1993.
3. 3 Catalona, W. J. and Bigg, S. W.: Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J. Urol., 143: 538, 1990.
4. 4 Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A. and Andriole, G. E.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
5. 5 Murphy, G. P., Natarajan, N., Pontes, J. E., Schmitz, R. L., Smart, R., Schmidt, J. D. and Mettlin, C.: The national survey of prostate cancer in the United States by the American College of Surgeons. J. Urol., 127: 928, 1982.
6. 6 Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A. and Goodman, P. J.: A controlled trial of leuprolide with and without flutamide in prostate carcinoma. New Engl. J. Med., 321: 419, 1989.
7. 7 Brawer, M. K, Chetner, M. P., Beatie, J., Buchner, D. M., Vessella, R. L. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., part 2, 147: 841, 1992.
8. 8 Cooner, W. H., Mosley, B. R., Rutherford, C. L., Jr., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C. and Kidd, D. D.: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J. Urol., 143: 1146, 1990.
9. 9 Coughlin, S. S., Trock, B., Criqui, M. H., Pickle, L. W., Browner, and Tefft, M. C.: The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J. Clin. Epidemiol., 45: 1, 1992.
10. 10 Richie, J. P., Catalona, W. J., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Effect of patient age on early detection of prostate cancer through serum prostate specific antigen (PSA) measurements and digital rectal examination. Urology 42: 365. 1993.
11. 11 Vallancien, G., Prapotnich, D., Veillon, B., Brisset, J. M. and Andre-Bougaran, J.: Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J. Urol., 146: 1308, 1991.
12. 12 Colberg, J. W., Smith, D. S. and Catalona, W. J.: Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml J Urol., 149: 507, 1993.
13. 13 Seaman, E., Katz, A., Cooner, W. C., Whang, I S., Olsson, C. A., Kistler, S. and Benson, M. C.: An algorithm for prostate cancer detection based upon PSA, TRUS, DRE, PSA density and PSA velocity. J. Urol., part 2, 149: 414A, abstract 805, 1993.
14. 14 Kinne, D. W. and Kopans, D. B.: Physical examination and mammography in the diagnosis of breast disease. In: Breast Disease. Edited by J. R. Harris. Philadelphia: J. B Lippincott Co. pp. 54–86, 1987.
15. 15 Moskowitz, M.: Cost-benefit determinations in screening mammography. Cancer, suppl., 60: 1680, 1987.
16. 16 Scardino, P. T., Weaver, R. and Hudson, M. A.: Early detection of prostate cancer. Hum. Path., 23: 211, 1992.
17. 17 Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A., Whittemore, A. S. and Schmid, H.-P.: Relationship of tumor volume to clinical significance for treatment of prostate cancer. J. Urol., part 2, 147: 303A, abstract 364, 1992.
18. 18 Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone I. M., Freiha, F., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J. Urol., 141: 1076, 1989.
19. 19 Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha. F. S., and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J Med., 317: 909, 1987.
20. 20 Walsh, P. C.: Why make an early diagnosis of prostate cancer. J. Urol., part 2, 147: 853, 1992.
21. 21 Brawn, P. N., Speights, V. O., Kuhl, D., Riggs, M., Spiekerman, A. M., McCord, R. G., Coffield, K. S., Stewart, D. T. and Lind, M. L.: Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer, 68: 1592, 1991.
22. 22 Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
23. 23 Stormont, T. J., Farrow, G. M., Myers, R. P., Blute, M. L., Zincke, H., Wilson, T. M. and Oesterling, J. E.: Clinical stage BO or Tlc prostate cancer: nonpalpable disease identified by an elevated serum prostate-specific antigen concentration. Urology, 41: 3, 1993.
24. 24 McNeal, J. E.: Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread, Hum. Path., 23: 258, 1992.
25. 25 Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C.: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. J.A.M.A., 267: 2215, 1992.
26. 26 Beatie, J. and Brawer, M. K.: Prostate specific antigen as the initial test in the early detection of carcinoma: results of the second year screening. J. Urol., part 2, 147: 386A, abstract 696, 1992.
27. 27 Zhou, A., Tewari, P., Bonacci, M., Walsh, R., Larsen, F., stamey, T. and Bluestein, B.: Complexation of prostate specific antigen (PSA) in serum. Clin. Chem., 38: 982, abstract 0202, 1992.
28. 28 Turkes, A., Nott, J. P. and Griffths, K.: Prostate-specific antigen: problems in analysis. Eur. J. Cancer, 27: 650, 1991.
29. 29 Steinberg, G. D., Carter, B. S., Beaty, T. H., Childs, B. and Walsh, P. C.: Family history and the risk of prostate cancer. Prostate, 17: 337, 1990.
30. 30 Fleming, C., Wasson, J. H., Albertsen, P. C., Barry, M. J. and Wennberg, J. E. for the Prostate Patient Outcomes Research Team.: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. J.A.M.A., 269: 2650.
31. 31 Simpson, K. N. and Brown, R. E.: Cost effectiveness of adding prostate specific antigen (PSA) test to digital rectal examination (DRE) for early detection of prostate cancer. J.Urol., part 2, 149: 413A, abstract 802, 1993.